Loss of heterozygosity in human ovarian cancer on chromosome 19q

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 36-40

  Bicher, Annette ^a   Ault, Kristen ^a   Kimmelman, Alec ^a   Gershenson, David ^b   Reed, Eddie ^a   Liang, Bertrand ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 19Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DNA REPAIR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031194658     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4709     Document Type: Article

References (25)

1. Parker S L, Tong T, Bolden S, Wingo P A. Cancer statistics, 1996. CA Cancer J Clin. 65:1995;5-27.
2. Ozols R F, Rubin S C, Dembo A J, Robboy S J. Epithelial Ovarian Cancer. Principles and Practice of Gynecologic Oncology. 1992;Lippincott, Philadelphia. p. 731-782.
3. Yong W H, Chou D, Ueki K, Harsh G R, vonDeimling A, Gusella J F, Mohrenweiser H W, Lewis D N. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112. J Neuropathol Exp Neurol. 54:1995;622-626.
4. Cliby W, Ritland S, Hartmann L, Dodson M, Halling K C, Keeney G, Podratz K C, Jenkins R B. Human epithelial ovarian cancer allelotype. Cancer Res. 53:1993;2393-2398.
5. Shelling A N, Cooke I E, Ganesan T S. The genetic analysis of ovarian cancer. Br J Cancer. 72:1995;521-527.
6. Osborne R J, Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer. 69:1994;429-439.
7. Jenkins R B, Bartelt D Jr, Stalboerger P, Persons D, Dahl R J, Podartz K, Keeney G, Hartmann L. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet. 71:1993;76-86.
8. Gallion H H, Powell D E, Morrow J K, Pieretti M, Case E, Turker M S, DePriest P D, Hunter J E, van Nagell J R Jr. Molecular genetic changes in human epithelial ovarian malignancies. Gynecol Oncol. 47:1992;137-142.
9. Dabholkar M, Bostick-Bruton F, Reed E. ERCC1 and ERCC2 expression in fresh human tumor tissues. J Natl Cancer Inst. 84:1992;1512-1517.
10. Dabholkar M D, Berger M S, Vionnet J A, Egwuagu C, Silber J R, Yu J J, Reed E. Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res. 55:1995;1-6.
11. Liang B C, Ross D A, Reed E. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas. J Neuro-Oncol. 26:1995;17-23.
12. Thompson F H, Nelson M A, Trent J M, Guan X, Liu Y, Yang J, Emerson J, Adair L, Wymer J, Balfour C, Massey K, Weinstein R, Alberts D S, Teatle R. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. Cancer Genet Cytogenet. 87:1996;55-62.
13. Reifenberger J, Reifenberger G, Liu L, James C D, Wechsler W, Collins V P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol. 145:1994;1175-1190.
14. Bello M J, Leone P E, Nebreda P, Kusak M E, DeCampos J M, Vaquero J, Sarasa J L, Pestana A, Rey J A. Molecular abnormalities of chromosome 19 in malignant gliomas: preferntial involvement of the 19q13.2-19q13.4 region. Int J Oncol. 6:1995;655-658.
15. Bello M J, Leone P E, Vaquero J, De Campos J M, Kusak M E, Sarasa J L, Pestana A, Rey J A. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer. 64:1995;207-210.
16. Ritland S R, Ganju V, Jenkins R B. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom Cancer. 12:1995;277-282.
17. vonDeimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis D N, Wiestler O D. Deletion mapping of chromosome 19 in human gliomas. Int J Cancer. 57:1994;676-680.
18. Rubio M P, Correa D M, Ueki K, Mohrenweiser H W, Gusella J F, von Deimling A, Louis D N. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Cancer Res. 54:1994;4760-4763.
19. Buetow K H, Weber J L, Ludwigsen S, Scherpbier-Heddema T, Duyk G M, Sheffield V C, Wang Z, Murray J C. Integrated human genome-wide maps constructed using the CEPH reference panel. Nature Genet. 6:1994;391-393.
20. Weber J L, Wang Z, Hansen K, Stephenson M, Kappel C, Salzman S, Wilkie P J, Keats B, Dracopoli N C, Brandriff B F, Olsen A S. Evidence for human meiotic recombination interference obtained through construction of a short tandem repeat-polymorphism linkage map of chromosome 19. Am J Hum Genet. 53:1993;1079-1095.
21. Gordon L A, Bergmann A, Christensen M, Danganan L, Lee D A, Ashworth L K, Nelson D O, Olsen A S, Mohrenwieser H W, Carrano A V, Brandriff B F. A 30-MB metric flourescence in situ hybridization map of human chromosome 19q. Genomics. 30:1995;187-192.
22. Ashworth L K, Batzer M A, Brandriff B, Branscomb E, deJong P, Garcia E, Garnes J A, Gordon L A, Lamerdin J E, Lennon G, Mohrenweiser H, Olsen A S, Slezak T, Carrano A V. An integrated metric physical map of human chromosome 19. Nature Genet. 1:1995;422-427.
23. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Plainview. p. E3-E7.
24. Amfo K, Neyns B, Teugels E, Lissens W, Bourgain C, De Sutter P, Vandamme B, Vamos E, De Greve J. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer. Oncogene. 11:1995;351-358.
25. Kiechle-Schwarz M, Bauknecht T, Karck U, Kommoss F, DuBois A, Pfleiderer A. Recurrent cytogenetic aberration and loss of constitutional heterozygosity in ovarian carcinomas. Gynecol Oncol. 55:1994;198-205.